INBX

Inhibrx, Inc. Common Stock

Delisted

INBX was delisted on the 29th of May, 2024.

102 hedge funds and large institutions have $512M invested in Inhibrx, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 12 closing their positions.

Holders
102
Holders Change
+2
Holders Change %
+2%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
46
Reduced
27
Closed
12
Calls
$369K
Puts
$12.7M
Net Calls
-$12.3M
Net Calls Change
-$12.5M
Name Holding Trade Value Shares
Change
Shares
Change %
LC
101
Lindbrook Capital
California
$1K -$2.54K -104 -72%
Capital World Investors
102
Capital World Investors
California
-$18.5M -1,631,547 Closed
SCM
103
Sio Capital Management
New York
-$4.15M -365,210 Closed
Verition Fund Management
104
Verition Fund Management
Connecticut
-$1.08M -95,076 Closed
ECM
105
ExodusPoint Capital Management
New York
-$763K -67,233 Closed
IC
106
Ikarian Capital
Texas
-$561K -49,372 Closed
Qube Research & Technologies (QRT)
107
Qube Research & Technologies (QRT)
United Kingdom
-$453K -39,875 Closed
HF
108
HRT Financial
New York
-$339K -29,900 Closed
UBS AM
109
UBS AM
Illinois
-$114K -10,080 Closed
QT
110
Quantbot Technologies
New York
-$67K -5,915 Closed
PHK
111
Point72 Hong Kong
Hong Kong
-$33K -2,879 Closed